On Mar 2, 2022 Rialtic closed a Series A round and raised $28,000,000 from F-Prime Capital, Health Velocity Capital, Noro-Moseley Partners, Oak HC/FT, featuring lead […]
Series A – Alimetry
On Mar 2, 2022 Alimetry closed a Series A round and raised $16,300,000 from IP Group, K1W1, Matū Fund, Movac, Uniservices, featuring lead investors Movac. […]
Series A – Stämm Biotech
On Feb 28, 2022 Stämm Biotech closed a Series A round and raised $17,000,000 from Decarbonization Consortium, Dragones VC, Draper Associates, Draper Cygnus, GRID EXPONENTIAL, […]
Series A – CVAid Medical
On Feb 28, 2022 CVAid Medical closed a Series A round and raised $4,000,000 from Koninklijke Philips, RAD BioMed Accelerator, Sanara Ventures, featuring lead investors […]
Series A – Engimmune Therapeutics
On Feb 21, 2022 Engimmune Therapeutics closed a Series A round and raised CHF500,000 from BaseLaunch, featuring lead investors BaseLaunch. About the company: Engimmune Therapeutics […]
Series A – Mediintech
On Feb 21, 2022 Mediintech closed a Series A round and raised ₩8,000,000,000 from Atinum Investment, FuturePlay, Smilegate Investment, featuring lead investors . About the […]
Series A – Gaia
On Feb 14, 2022 Gaia closed a Series A round and raised $20,000,000 from Atomico, Clocktower Technology Ventures, Kindred Capital, Seedcamp, featuring lead investors Atomico. […]
Series A – Kevala
On Feb 14, 2022 Kevala closed a Series A round and raised $12,100,000 from Cercano Management, Costanoa Ventures, High Alpha, PSL Ventures, featuring lead investors […]
Series A – Ucello Therapeutics
On Feb 10, 2022 Ucello Therapeutics closed a Series A round and raised $25,000,000 from Chengdu Tianfu International Bio-Town Investment & Development, Cowin Venture, Elikon […]
Series A – QbDVision
On Feb 10, 2022 QbDVision closed a Series A round and raised $15,000,000 from Hudson Park Capital, Northpond Ventures, S3 Ventures, Wanxiang America Healthcare Investments […]
